Elevance Health Inc (ELV)vsRLX Technology Inc (RLX)
ELV
Elevance Health Inc
$415.53
-0.71%
HEALTHCARE · Cap: $87.28B
RLX
RLX Technology Inc
$2.00
-0.99%
CONSUMER DEFENSIVE · Cap: $2.51B
Smart Verdict
WallStSmart Research — data-driven comparison
Elevance Health Inc generates 4477% more annual revenue ($200.42B vs $4.38B). RLX leads profitability with a 22.5% profit margin vs 2.6%. ELV trades at a lower P/E of 17.0x. RLX earns a higher WallStSmart Score of 68/100 (B-).
ELV
Buy56
out of 100
Grade: C
RLX
Strong Buy68
out of 100
Grade: B-
Intrinsic Value Comparison
Multi-model valuation · Graham Formula
Margin of Safety
+4.5%
Fair Value
$416.35
Current Price
$415.53
$0.82 discount
Intrinsic value data unavailable for RLX.
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Large-cap with strong market position
Attractively priced relative to earnings
Reasonable price relative to book value
Generating 4.1B in free cash flow
Reasonable price relative to book value
Revenue surging 107.4% year-over-year
Conservative balance sheet, low leverage
Safe zone — low bankruptcy risk
Keeps 23 of every $100 in revenue as profit
Earnings expanding 27.1% YoY
Areas to Watch
2.6% revenue growth
2.6% margin — thin
Earnings declined 16.8%
ROE of 6.2% — below average capital efficiency
Comparative Analysis Report
WallStSmart ResearchBull Case : ELV
The strongest argument for ELV centers on Market Cap, P/E Ratio, Price/Book. PEG of 1.47 suggests the stock is reasonably priced for its growth.
Bull Case : RLX
The strongest argument for RLX centers on Price/Book, Revenue Growth, Debt/Equity. Profitability is solid with margins at 22.5% and operating margin at 16.7%. Revenue growth of 107.4% demonstrates continued momentum.
Bear Case : ELV
The primary concerns for ELV are Revenue Growth, Profit Margin, EPS Growth. Thin 2.6% margins leave little buffer for downturns.
Bear Case : RLX
The primary concerns for RLX are Return on Equity.
Key Dynamics to Monitor
ELV profiles as a value stock while RLX is a growth play — different risk/reward profiles.
RLX carries more volatility with a beta of 1.14 — expect wider price swings.
RLX is growing revenue faster at 107.4% — sustainability is the question.
ELV generates stronger free cash flow (4.1B), providing more financial flexibility.
Bottom Line
RLX scores higher overall (68/100 vs 56/100), backed by strong 22.5% margins and 107.4% revenue growth. Both earn "Strong Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Elevance Health Inc
HEALTHCARE · HEALTHCARE PLANS · USA
Elevance Health Inc. is a health benefits company. The company is headquartered in Indianapolis, Indiana.
RLX Technology Inc
CONSUMER DEFENSIVE · TOBACCO · China
RLX Technology Inc., researches, develops, manufactures, distributes and sells e-vapor products in the People's Republic of China. The company is headquartered in Beijing, China.
Visit Website →Compare with Other HEALTHCARE PLANS Stocks
Want to dig deeper into these stocks?